Waystar (NASDAQ:WAY) Upgraded by Barclays to Strong-Buy Rating

Waystar (NASDAQ:WAY) was upgraded by investment analysts at Barclays to a “strong-buy” rating in a report issued on Wednesday,Zacks.com reports.

Several other research firms have also recently weighed in on WAY. The Goldman Sachs Group decreased their price target on Waystar from $44.00 to $38.00 and set a “buy” rating for the company in a research note on Wednesday, February 18th. Weiss Ratings upgraded Waystar from a “sell (d+)” rating to a “hold (c-)” rating in a research report on Monday, May 4th. TD Cowen reiterated a “buy” rating on shares of Waystar in a research report on Wednesday, February 18th. Freedom Capital upgraded Waystar from a “hold” rating to a “strong-buy” rating in a research report on Wednesday, February 18th. Finally, Needham & Company LLC reiterated a “buy” rating and set a $33.00 price objective on shares of Waystar in a research report on Thursday, April 30th. Four equities research analysts have rated the stock with a Strong Buy rating, sixteen have given a Buy rating and three have given a Hold rating to the stock. According to data from MarketBeat, the company currently has a consensus rating of “Buy” and a consensus price target of $35.62.

Waystar Stock Down 2.0%

WAY stock opened at $19.21 on Wednesday. Waystar has a 1-year low of $17.89 and a 1-year high of $41.49. The business has a fifty day moving average price of $23.09 and a 200-day moving average price of $28.09. The company has a debt-to-equity ratio of 0.37, a current ratio of 1.76 and a quick ratio of 1.76. The stock has a market capitalization of $3.68 billion, a P/E ratio of 28.67, a P/E/G ratio of 0.78 and a beta of 0.21.

Waystar (NASDAQ:WAY) last posted its quarterly earnings results on Wednesday, April 29th. The company reported $0.42 earnings per share for the quarter, topping the consensus estimate of $0.39 by $0.03. Waystar had a return on equity of 6.99% and a net margin of 10.90%.The firm had revenue of $313.87 million during the quarter, compared to analysts’ expectations of $311.74 million. During the same quarter in the previous year, the business earned $0.32 earnings per share. The company’s revenue was up 22.4% on a year-over-year basis. Waystar has set its FY 2026 guidance at 1.590-1.680 EPS. Equities analysts forecast that Waystar will post 1.45 earnings per share for the current fiscal year.

Institutional Trading of Waystar

Hedge funds have recently bought and sold shares of the stock. ANTIPODES PARTNERS Ltd grew its holdings in Waystar by 120.1% during the third quarter. ANTIPODES PARTNERS Ltd now owns 823 shares of the company’s stock valued at $31,000 after purchasing an additional 449 shares during the period. Root Financial Partners LLC grew its holdings in Waystar by 6,475.0% during the first quarter. Root Financial Partners LLC now owns 1,052 shares of the company’s stock valued at $25,000 after purchasing an additional 1,036 shares during the period. Smartleaf Asset Management LLC grew its holdings in Waystar by 6,005.3% during the fourth quarter. Smartleaf Asset Management LLC now owns 1,160 shares of the company’s stock valued at $38,000 after purchasing an additional 1,141 shares during the period. EverSource Wealth Advisors LLC grew its holdings in Waystar by 3,219.0% during the second quarter. EverSource Wealth Advisors LLC now owns 1,394 shares of the company’s stock valued at $57,000 after purchasing an additional 1,352 shares during the period. Finally, Danske Bank A S bought a new stake in Waystar during the fourth quarter valued at about $52,000.

Waystar Company Profile

Waystar (NASDAQ:WAY) is a leading provider of cloud-based revenue cycle management and payment solutions for healthcare organizations. The company’s unified platform streamlines the entire financial continuum of patient care, from eligibility verification and claim submission to payment reconciliation and patient billing. By automating key processes and improving claim accuracy, Waystar helps providers reduce administrative overhead, accelerate cash flow and enhance overall revenue performance.

At the core of Waystar’s offering is a SaaS-based architecture that integrates seamlessly with existing electronic health record (EHR) systems and payer networks.